Search research articles
Contact Us
Filters
Showing results (51-60 of 216) with videos related to
Page
of 22
Sort By:
Nature Cancer
|
March 20, 2024
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies
Anton Dobrin, Pieter L Lindenbergh, Yuzhe Shi, et al.
Blood
|
November 25, 2003
Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia
Carmela Gurrieri, Khedoudja Nafa, Taha Merghoub, et al.
Science Advances
|
February 25, 2022
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism
Changhao He, Rachana R Maniyar, Yahel Avraham, et al.
Cancer Immunology Research
|
January 14, 2014
GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability
David A Schaer, Sadna Budhu, Cailian Liu, et al.
Oncotarget
|
July 10, 2018
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
Anton Oseledchyk, Jacob M Ricca, Mathieu Gigoux, et al.
Cancer Immunology Research
|
May 6, 2014
Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates
Francesca Avogadri, Roberta Zappasodi, Arvin Yang, et al.
The Journal of Experimental Medicine
|
May 6, 2009
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
Daniel Hirschhorn-Cymerman, Gabrielle A Rizzuto, Taha Merghoub, et al.
Cancer Immunology Research
|
December 14, 2016
Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade
Tavi Nathanson, Arun Ahuja, Alexander Rubinsteyn, et al.
Blood
|
February 16, 2010
Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
Takeshi Nakahara, Hiroshi Uchi, Alexander M Lesokhin, et al.
Oncoimmunology
|
May 10, 2019
Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer
Souhil Lebdai, Mathieu Gigoux, Ricardo Alvim, et al.
Page
of 22
Search research articles
Search
Showing results (51-60 of 216) with videos related to
Sort By:
Page
of 22
Nature Cancer
|
March 20, 2024
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies
Anton Dobrin, Pieter L Lindenbergh, Yuzhe Shi, et al.
Blood
|
November 25, 2003
Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia
Carmela Gurrieri, Khedoudja Nafa, Taha Merghoub, et al.
Science Advances
|
February 25, 2022
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism
Changhao He, Rachana R Maniyar, Yahel Avraham, et al.
Cancer Immunology Research
|
January 14, 2014
GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability
David A Schaer, Sadna Budhu, Cailian Liu, et al.
Oncotarget
|
July 10, 2018
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
Anton Oseledchyk, Jacob M Ricca, Mathieu Gigoux, et al.
Cancer Immunology Research
|
May 6, 2014
Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates
Francesca Avogadri, Roberta Zappasodi, Arvin Yang, et al.
The Journal of Experimental Medicine
|
May 6, 2009
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
Daniel Hirschhorn-Cymerman, Gabrielle A Rizzuto, Taha Merghoub, et al.
Cancer Immunology Research
|
December 14, 2016
Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade
Tavi Nathanson, Arun Ahuja, Alexander Rubinsteyn, et al.
Blood
|
February 16, 2010
Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
Takeshi Nakahara, Hiroshi Uchi, Alexander M Lesokhin, et al.
Oncoimmunology
|
May 10, 2019
Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer
Souhil Lebdai, Mathieu Gigoux, Ricardo Alvim, et al.
Page
of 22